z-logo
Premium
Validation of the protective Ostertagia ostertagi ES‐thiol antigens with different adjuvantia
Author(s) -
Geldhof P.,
Vercauteren I.,
Vercruysse J.,
Knox D. P.,
Van Den Broeck W.,
Claerebout E.
Publication year - 2004
Publication title -
parasite immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.795
H-Index - 75
eISSN - 1365-3024
pISSN - 0141-9838
DOI - 10.1111/j.0141-9838.2004.00681.x
Subject(s) - ostertagia ostertagi , biology , immunology , antigen , ostertagia , helminths
SUMMARY Intramuscular immunization of calves with an excretory–secretory antigen fraction enriched for cysteine proteinase activity (ES‐thiol) and QuilA as adjuvant induces a protective immune response against the abomasal nematode Ostertagia ostertagi . The objectives of the present study were to confirm the protective capacity of ES‐thiol in combination with QuilA, to test Al(OH) 3 as adjuvant for vaccination against O. ostertagi and to look for correlations between protection and immunological effector responses. Calves(seven animals/group) were vaccinated three times intramuscularly with 100 µg antigen and/or adjuvant (ES‐thiol with QuilA, ES‐thiol with Al(OH) 3 , QuilA alone and Al(OH) 3 alone) and subsequently challenged with a trickled oral infection of 25 000 infective larvae in total over 25 days. Faecal egg counts in the ES‐thiol QuilA group were reduced by 56% during the two‐month period of the trial compared to the QuilA control group ( P <  0·002). Calves immunized with ES‐thiol QuilA had significantly smaller adult worms ( P <  0·002) and less eggs/female worm ( P <  0·05) compared to the QuilA control group. No differences in egg output, worm counts or parameters of worm fitness were observed in the ES‐thiol Al(OH) 3 group compared to the Al(OH) 3 control group. Although the protective immune mechanism against O. ostertagi remains unknown, protection in the ES‐thiol QuilA group was associated with high levels of parasite‐specific antibodies in the abomasal mucosa.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here